.jpg)
tHEORetically Speaking
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
Episodes
82 episodes
Weekly News Roundup — Medtech Mega Deals, EU Regulatory Delays, and Global Supply Chain Shock
This week’s tHEORetically Speaking News Roundup covers Abbott’s $21 billion acquisition of Exact Sciences, signaling a major expansion in cancer d...
•
Season 5
•
Episode 13
•
2:40
Weekly News Roundup — Medicaid Maternal Care Expansion, Breakthrough Diabetes Data, and SMA Market Shakeups
This week’s tHEORetically Speaking News Roundup covers Nadia Care’s $12M raise to expand Medicaid-focused maternal care,
•
Season 5
•
Episode 12
•
2:31
Weekly News Roundup — Biosimilar Policy Changes, mRNA Leadership Shifts, and Rare Disease Market Growth
This week’s tHEORetically Speaking News Roundup covers the FDA’s new guidance aimed at streamlining biosimilar development an...
•
Season 5
•
Episode 11
•
4:07
Weekly News Roundup — mRNA Vaccine Milestones, Obesity Drug Manufacturing, and Gene Therapy Regulatory Tensions
This week’s tHEORetically Speaking News Roundup covers Moderna’s progress toward European approval of its combination COVID-19 and flu mRNA vaccine,...
•
Season 5
•
Episode 10
•
3:58
INsights & OUTcomes with Radek Wasiak
This episode features Radek Wasiak, an expert in real world data generation, and real-world evidence. He has provided research services to the life sciences for more than two decades and is currently the director of
•
Season 5
•
Episode 9
•
25:43
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
In this episode, we explore why the traditional 'clinical-first, value-later' model is becoming a strategic liability and why integrating HEOR into CRO operations is the new industry standard. Join us as Aaron Berger and Dr. Mir Sohail Fazeli b...
•
Season 5
•
Episode 8
•
31:49
Weekly News Roundup — RSV Breakthrough Data, Psychedelic Approvals on the Horizon, and Major FDA Policy Shifts
This week’s tHEORetically Speaking News Roundup covers new real-world data showing Sanofi’s Beyfortus delivering...
•
Season 5
•
Episode 7
•
4:39
Weekly News Roundup — AI Drug Discovery Deals, mRNA Regulatory Setbacks, and Global Investment Shifts
This week’s tHEORetically Speaking News Roundup covers Takeda’s $1.7B AI-powered drug discovery partnership with Iambic,
•
Season 5
•
Episode 6
•
4:01
Weekly News Roundup — Regulatory RWE Battles, Capital Market Moves, and Cash-Pay Drug Pricing Disruption
This week's tHEORetically Speaking News Roundup covers Humana’s rollout of a Google Cloud–powered AI tool to streamline 80 million annual ...
•
Season 5
•
Episode 5
•
4:36
INsights & OUTcomes with Taylor Hirschberg
This episode features Taylor Hirschberg, an award winning writer, activist, and academic. He is the CEO of Metli Consulting, an inclusive consultancy firm focused on helping to prepare for launch a...
•
Season 5
•
Episode 4
•
27:54
Weekly News Roundup — Rare Disease Funding Risks, Medicare Advantage Reform, and Global Trade Shifts
This week’s tHEORetically Speaking News Roundup covers the looming funding crisis for rare disease biotechs as FDA priority review vouc...
•
Season 5
•
Episode 3
•
4:43
Weekly News Roundup — Oral GLP-1 Momentum, Trade Tensions, EU Drug Security, and AI Risk Warnings
This week’s tHEORetically Speaking News Roundup covers Novo Nordisk’s early momentum with oral Wegovy amid intensifying G...
•
Season 5
•
Episode 2
•
3:13
Weekly News Roundup — Neurodegeneration Deals, Generative AI, and Drug Pricing Politics
This week’s tHEORetically Speaking News Roundup covers Novartis’ $1.5B Alzheimer’s licensing deal, the
•
Season 5
•
Episode 1
•
3:51
Weekly News Roundup — Oncology Shakeups, FDA Wellness Crackdown, and AI-Powered Drug Discovery
This week’s tHEORetically Speaking News Roundup covers GSK’s abrupt exit from its five-year synthetic lethality partnership with Ideaya
•
Season 4
•
Episode 28
•
3:21
Weekly News Roundup — Tariff-Free Pharma, Biologics Modernization, Duchenne Trial Success, and Maternal Health Advances
This week’s tHEORetically Speaking News Roundup breaks down four major developments shaping policy and biopharma. We cover the ne...
•
Season 4
•
Episode 27
•
3:58
Weekly News Roundup — Premium Hikes, Predictive AI Breakthroughs, and Public Health Policy Fallout
This week’s tHEORetically Speaking News Roundup covers Medicare’s 10% Part B premium hike for 2026 and its potential to push m...
•
Season 4
•
Episode 26
•
3:55
Weekly News Roundup — Four Big Moves in Medtech, Neurotech, Biopharma R&D & Pharma M&A
This week on tHEORetically Speaking, we’re covering four major stories shaping the landscape across medtech, neurotech, drug development, and global pharma:
•
Season 4
•
Episode 25
•
2:49
Weekly News Roundup – FDA Shakeups, Novo Nordisk’s Strategic Reset, and Smart Data for Diabetes Innovation
This week’s tHEORetically Speaking News Roundup covers the sudden resignation of the FDA’s top drug chief amid controversy,
•
Season 4
•
Episode 24
•
4:16
Weekly News Roundup – Neuro Breakthroughs, Biosimilar Reform, and an Obesity Drug Showdown
This week’s tHEORetically Speaking News Roundup covers Evotec and Bristol Myers Squibb’s progress in dev...
•
Season 4
•
Episode 23
•
3:59
Weekly News Roundup – Real-World Wins and Billion-Dollar Breakthroughs
This week’s tHEORetically Speaking News Roundup covers Astellas Pharma’s Phase 4 findings showing fezolinetan...
•
Season 4
•
Episode 22
•
3:50
INsights & OUTcomes with Dalfoni Banerjee
This episode features Dalfoni Banerjee, an award-winning entrepreneur and consultant with over 30 years of hands-on experience and her expertise spans the full drug development cycle. In 2011, Dalfoni founded and continues to operat...
•
Season 4
•
Episode 21
•
18:24
Weekly News Roundup – CAR-T Safety Alerts, Policy Ripple Effects, and Notable Wearables
This week’s tHEORetically Speaking News Roundup covers the FDA’s new boxed warning for J&J’s CAR-T therapy Carvykti
•
Season 4
•
Episode 20
•
3:50
Weekly News Roundup – Immunology, Innovation, and Impact
This week’s tHEORetically Speaking News Roundup covers nirsevimab’s real-world success in reducing RSV hospit...
•
Season 4
•
Episode 19
•
3:59
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
In this episode of tHEORetically Speaking, Paige McGarry interviews Aaron Berger, SVP & Head of Evidence Development Solutions at UBC discussing the evolution of direct-to-patient (DTP) study designs and how they are reshaping the landscape...
•
Season 4
•
Episode 18
•
14:21
